LMO3 and CEP170P1

Number of citations of the paper that reports this interaction (PMID 16189514)
699

Data Source:
BioGRID (two hybrid)

		LMO3	CEP170P1
Gene Name		LIM domain only 3 (rhombotin-like 2)	centrosomal protein 170kDa pseudogene 1
Image		No pdb structure	No pdb structure
Gene Ontology Annotations	Cellular Component	Cytoplasm
	Molecular Function	Zinc Ion Binding	Identical Protein Binding
	Biological Process	Transcription, DNA-templated Regulation Of Transcription, DNA-templated Positive Regulation Of Peroxisome Proliferator Activated Receptor Signaling Pathway Positive Regulation Of Fat Cell Differentiation Negative Regulation Of ERK1 And ERK2 Cascade Positive Regulation Of Glucocorticoid Receptor Signaling Pathway
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions		33 interactors: AIMP2 BANP CARF CCDC33 CCDC85B CEP170P1 CEP57L1 FAM131C FBLIM1 FOS GABPB1 HNRNPC HNRNPM IKZF1 KCTD1 KXD1 LDB1 LDB2 MBIP MDFI NBPF22P NHLH2 NUTM1 PHC2 RALYL RFX6 RORA SAMD3 SP4 SPERT TAX1BP1 ZBTB43 ZBTB8A	21 interactors: ABI3 AIMP2 ARHGDIG C19orf25 C1orf216 CCAR2 CCDC120 CCDC146 CENPO CLHC1 HAUS1 KIFC3 KXD1 LMO1 LMO3 LMO4 OIP5 RALYL RUNX1T1 SMARCE1 SSC5D
Entrez ID		55885	645455
HPRD ID		11832
Ensembl ID		ENSG00000048540	ENSG00000154608
Uniprot IDs		Q8TAP4 Q9NYC6
PDB IDs
Enriched GO Terms of Interacting Partners?		RNA Metabolic Process Gene Expression Transcription, DNA-templated RNA Biosynthetic Process Regulation Of Gene Expression Regulation Of Transcription, DNA-templated Regulation Of Nucleic Acid-templated Transcription Regulation Of RNA Biosynthetic Process Regulation Of RNA Metabolic Process Nucleobase-containing Compound Metabolic Process Heterocycle Metabolic Process Cellular Aromatic Compound Metabolic Process Cellular Macromolecule Biosynthetic Process Regulation Of Nitrogen Compound Metabolic Process Macromolecule Biosynthetic Process Positive Regulation Of Transcription From RNA Polymerase II Promoter Cellular Nitrogen Compound Metabolic Process Regulation Of Metabolic Process Regulation Of Transcription From RNA Polymerase II Promoter Nitrogen Compound Metabolic Process Positive Regulation Of Transcription, DNA-templated Positive Regulation Of Macromolecule Biosynthetic Process Positive Regulation Of Gene Expression Biosynthetic Process Positive Regulation Of Cellular Biosynthetic Process Positive Regulation Of Cellular Metabolic Process Cerebellar Purkinje Cell Differentiation Cerebellar Purkinje Cell Layer Morphogenesis Epithelial Structure Maintenance Transcription From RNA Polymerase II Promoter Cell Differentiation Positive Regulation Of Metabolic Process Chromatin Modification Cerebellar Cortex Formation Cell Differentiation In Hindbrain Cerebellar Purkinje Cell Layer Development Cellular Metabolic Process Chromatin Organization Regulation Of Myeloid Cell Differentiation Cerebellar Cortex Morphogenesis Cellular Response To Calcium Ion Histone H3 Acetylation Positive Regulation Of Neutrophil Differentiation Histone H3-K4 Acetylation Inactivation Of MAPK Activity Involved In Osmosensory Signaling Pathway Pancreatic Epsilon Cell Differentiation Positive Regulation Of Transcription From RNA Polymerase II Promoter In Response To Calcium Ion Transcription-dependent Tethering Of RNA Polymerase II Gene DNA At Nuclear Periphery Pancreatic D Cell Differentiation Positive Regulation Of Myeloid Leukocyte Differentiation	ATP-dependent Chromatin Remodeling Nucleosome Organization Chromatin Assembly Or Disassembly CENP-A Containing Nucleosome Assembly Chromatin Remodeling Histone Exchange DNA Replication-independent Nucleosome Assembly Centromere Complex Assembly Positive Regulation Of DNA Damage Checkpoint Positive Regulation Of Glucocorticoid Receptor Signaling Pathway Zonula Adherens Maintenance Negative Regulation Of Interleukin-8 Secretion Nucleosome Assembly Chromatin Assembly
Tagcloud ?		aggressive aggressiveness atypical benign biosignatures clinically constitute decisions demand forty fourteen histologically igf1r meningioma meningiomas metabolic mostly nmr oligonucleotide otherwise predominant proceeds profiles recur recurrence relevance subgroup subgroups turnover
Tagcloud (Difference) ?		aggressive aggressiveness atypical benign biosignatures clinically constitute decisions demand forty fourteen histologically igf1r meningioma meningiomas metabolic mostly nmr oligonucleotide otherwise predominant proceeds profiles recur recurrence relevance subgroup subgroups turnover
Tagcloud (Intersection) ?